FRAME Scientific Liaison Officer Amy Beale discusses the current COVID-19 crisis and how it may provide unique insights into the value of animal and non-animal approaches in vaccine development.
Two researchers from the FRAME Alternatives Laboratory (FAL) recently volunteered at the Alderley Park Lighthouse Lab in Cheshire – one of three national megalabs testing COVID-19 samples.
Two researchers from the FRAME Alternatives Laboratory (FAL) recently volunteered at the Alderley Park Lighthouse Lab in Cheshire – one of three national megalabs testing COVID-19 samples.
FRAME Scientific Liaison Officer Amy Beale discusses the issue and consequences of poor reproducibility in animal research and why reproducibility needs to become a priority for research teams.
FRAME explains why Brexit could be an opportunity for the UK government to positively influence the legislation governing animal research and testing.
FRAME CEO Celean Camp shares her thoughts on why small charities are among the unsung heroes to commemorate Small Charities Week.
New research underway at the FRAME Alternatives Laboratory in Nottingham is focused on the development of insulin resistance in skeletal muscle (one of the first and most significant steps in the cascade that leads to Type II Diabetes).
In the UK today, there are 3.9 million people who have been diagnosed with diabetes and an estimated million more who have yet to be diagnosed. That’s approximately 1 in 15 UK citizens living with diabetes.
In celebration of Volunteers’ Week 2020, we’re taking a trip down memory lane with early supporter of FRAME, Susie Millar.
A paper recently published in Regulatory Toxicology and Pharmacology has highlighted opportunities to use one rather than two species for long-term toxicity testing.